Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Kyntra Bio Inc (KYNB) had Free Cash Flow of $-4.81M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$1.28M |
|
$-14.22M |
|
$0.28M |
|
$1.00M |
|
$14.79M |
|
$-13.51M |
|
$-1.10M |
|
$-14.61M |
|
$-14.61M |
|
$-14.61M |
|
$-14.61M |
|
$-14.22M |
|
$-14.61M |
|
$-13.51M |
|
$-13.58M |
|
4.04M |
|
4.04M |
|
$-3.61 |
|
$-3.61 |
|
| Balance Sheet Financials | |
$99.07M |
|
-- |
|
$20.52M |
|
$119.59M |
|
$29.24M |
|
-- |
|
$107.36M |
|
$136.60M |
|
$-17.01M |
|
$-17.00M |
|
$-17.00M |
|
4.05M |
|
| Cash Flow Statement Financials | |
$-4.77M |
|
$35.42M |
|
$-86.03M |
|
$102.18M |
|
$47.87M |
|
$-54.31M |
|
$6.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
78.31% |
|
-1058.10% |
|
-1058.11% |
|
-- |
|
-1144.01% |
|
-1113.55% |
|
|
Free Cash Flow |
$-4.81M |
-- |
|
-- |
|
-- |
|
0.01 |
|
0.07 |
|
5.91 |
|
15.22 |
|
85.91% |
|
85.91% |
|
-12.22% |
|
85.91% |
|
$-4.20 |
|
$-1.19 |
|
$-1.18 |
|